While further studies are necessary to understand the mechanism behind the inflammation that occurs as a result of AKT2 pathway dysregulation, our findings may be successfully extrapolated to the context of clinical diabetes as we provide evidence that both hyperinsulinemia and hypoinsulinemia cause an inflammatory phenotype that may be responsible for endothelial dysfunction. This evidence concerns the gene AKT2 and diabetes mellitus.